We are live on ! Find out more
GF

Gates Foundation Portfolio holdings

AUM $43.5M
1-Year Est. Return 14.19%
This Fund
S&P 500
This Quarter Est. Return
-12.77%
1 Year Est. Return
+14.19%
3 Year Est. Return
-58.08%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$342M
AUM Growth
-$309M
Cap. Flow
-$321M
Cap. Flow %
-93.83%
Top 10 Hldgs %
100%
Holding
10
New
2
Increased
–
Reduced
2
Closed
–

Top Buys

Rank Stock Value
1
LMDX
LumiraDx Limited Common Shares
LMDX
+$45.2M
2
SERA icon
Sera Prognostics
SERA
+$8.09M

Top Sells

Rank Stock Value
1
BNTX icon
BioNTech
BNTX
+$283M
2
VIR icon
Vir Biotechnology
VIR
+$90.9M

Sector Composition

Rank Sector Weight
1 Healthcare 98.83%
2 Materials 1.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CVAC
1
DELISTED
CureVac
CVAC
$171M 50.12%
3,134,780
– –
LMDX
2
DELISTED
LumiraDx Limited Common Shares
LMDX
$46.1M 13.5%
+5,574,059
New +$45.2M
BNTX icon
3
BioNTech
BNTX
$22.6B
$40.6M 11.89%
148,674
-890,000
-86% -$283M
VIR icon
4
Vir Biotechnology
VIR
$1.47B
$29.5M 8.64%
677,777
-2,100,000
-76% -$90.9M
IMCR icon
5
Immunocore
IMCR
$1.78B
$21.4M 6.26%
576,923
– –
BFLY icon
6
Butterfly Network
BFLY
$1.72B
$10.6M 3.1%
1,011,003
– –
SERA icon
7
Sera Prognostics
SERA
$80.3M
$8.7M 2.55%
+779,814
New +$8.09M
BCEL
8
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
$8.7M 2.55%
1,396,644
– –
AMRS
9
DELISTED
Amyris Inc.
AMRS
$4M 1.17%
292,398
– –
ZY
10
DELISTED
Zymergen Inc. Common Stock
ZY
$800K 0.23%
59,970
– –

Similar funds

NV
Northpond Ventures Bethesda, Maryland $43.7M AUM 27.27% 1-Year Est. Return
IV
Industry Ventures San Francisco, California $43.2M AUM 36.57% 1-Year Est. Return
RCM
Riverwood Capital Management Menlo Park, California $43.2M AUM 24% 1-Year Est. Return
EPWM
Essex Private Wealth Management Topsfield, Massachusetts $42.5M AUM 29.61% 1-Year Est. Return
SCMC
Serent Capital Management Company San Francisco, California $44.9M AUM 20.57% 1-Year Est. Return
GF
Genesis Fortune Grand Cayman, Cayman Islands $41.8M AUM 76.19% 1-Year Est. Return
AS
AM Squared Hong Kong $45.2M AUM 4.27% 1-Year Est. Return
BCP
Berylson Capital Partners Boston, Massachusetts $41.2M AUM 0.19% 1-Year Est. Return

Gates Foundation's Q3 2021 Portfolio in Review

As of Q3 2021, Gates Foundation held 10 positions worth $342M, down 48% from $651M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Gates Foundation withdrew a net $321M in Q3 2021, reducing 2 holdings. Its largest reduction was BioNTech, cutting an estimated $283M.

By sector, the portfolio is most concentrated in Healthcare at 99% of assets, down from 99% a quarter earlier, followed by Materials.

Against the trend, Gates Foundation opened a new position in LumiraDx Limited Common Shares worth $46.1M.

  • Gates Foundation's largest Q3 2021 buy was LumiraDx Limited Common Shares: 5,574,059 shares worth $46.1M.
  • Gates Foundation's biggest Q3 2021 reduction was BioNTech, cutting an estimated $283M.
  • Gates Foundation's ten largest holdings make up 100% of its $342M portfolio in Q3 2021.
  • Gates Foundation opened 2 new positions and closed 0 in Q3 2021.
  • Gates Foundation's portfolio value fell 48% quarter-over-quarter to $342M.

Based on Gates Foundation's 13F filing for Q3 2021, filed 15 Nov 2021.